ACRS Insider Trading

Insider Ownership Percentage: 6.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,640,944.49

Aclaris Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aclaris Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aclaris Therapeutics Share Price & Price History

Current Price: $17.53
Price Change: Price Decrease of -0.17 (-0.96%)
As of 11/25/2022 05:00 PM ET

This chart shows the closing price history over time for ACRS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aclaris Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/26/2022Andrew N SchiffDirectorSell14,540$17.00$247,180.00488,381View SEC Filing Icon  
10/24/2022Andrew N SchiffDirectorSell14,616$17.01$248,618.16514,939View SEC Filing Icon  
10/17/2022Andrew N SchiffDirectorSell19,944$16.05$320,101.20561,648View SEC Filing Icon  
10/17/2022Joseph MonahanInsiderSell5,000$15.98$79,900.00101,386View SEC Filing Icon  
10/6/2022Andrew N SchiffDirectorSell37,839$16.54$625,857.06588,916View SEC Filing Icon  
10/4/2022Andrew N SchiffDirectorSell7,700$16.01$123,277.00626,755View SEC Filing Icon  
6/17/2022Andrew N. SchiffDirectorSell19,565$15.14$296,214.10View SEC Filing Icon  
4/25/2022Neal WalkerCEOSell20,000$15.18$303,600.001,245,763View SEC Filing Icon  
4/21/2022Neal WalkerCEOSell25,000$15.24$381,000.001,290,763View SEC Filing Icon  
4/18/2022Joseph MonahanInsiderSell30,000$16.28$488,400.00106,386View SEC Filing Icon  
3/11/2022Neal WalkerCEOSell56,303$15.91$895,780.73View SEC Filing Icon  
3/10/2022Frank RuffoCFOSell12,823$15.55$199,397.65View SEC Filing Icon  
3/10/2022Joseph MonahanInsiderSell27,165$15.71$426,762.15View SEC Filing Icon  
2/9/2022Joseph MonahanInsiderSell383$12.68$4,856.44View SEC Filing Icon  
7/13/2021David N. GordonInsiderSell2,631$16.98$44,674.38147,447View SEC Filing Icon  
6/3/2021Kamil Ali-JacksonInsiderSell9,492$21.96$208,444.32122,196View SEC Filing Icon  
6/2/2021Neal WalkerCEOSell33,260$21.64$719,746.401,265,442View SEC Filing Icon  
6/1/2021David N. GordonInsiderSell14,000$23.01$322,140.00195,992View SEC Filing Icon  
5/7/2021Kamil Ali-JacksonInsiderSell5,416$23.52$127,384.32158,618View SEC Filing Icon  
5/5/2021Kamil Ali-JacksonInsiderSell15,000$23.98$359,700.00158,618View SEC Filing Icon  
5/3/2021Kamil Ali-JacksonInsiderSell15,000$24.59$368,850.00158,618View SEC Filing Icon  
4/26/2021Frank RuffoCFOSell27,339$25.80$705,346.20209,059View SEC Filing Icon  
4/22/2021Frank RuffoCFOSell30,000$26.84$805,200.00209,059View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

95.08% of Aclaris Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACRS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aclaris Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/22/2022Teachers Retirement System of The State of Kentucky54,011$0.85M0.0%N/A0.081%Search for SEC Filing on Google Icon
11/21/2022California State Teachers Retirement System65,616$1.03M0.0%+5.8%0.098%Search for SEC Filing on Google Icon
11/16/2022Balyasny Asset Management LLC106,147$1.67M0.0%N/A0.159%Search for SEC Filing on Google Icon
11/16/2022BNP Paribas Arbitrage SNC21,074$0.33M0.0%+57.8%0.032%Search for SEC Filing on Google Icon
11/15/2022State Street Corp1,303,027$20.51M0.0%+5.9%1.954%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.2,931,709$46.15M0.0%+4.2%4.396%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD47,106$0.74M0.0%+23.9%0.071%Search for SEC Filing on Google Icon
11/15/2022Parkman Healthcare Partners LLC233,626$3.68M1.0%-23.4%0.350%Search for SEC Filing on Google Icon
11/15/2022Laurion Capital Management LP1,304,624$20.54M0.1%-9.4%1.957%Search for SEC Filing on Google Icon
11/15/2022Ensign Peak Advisors Inc15,950$0.25M0.0%+45.4%0.024%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp233,882$3.68M0.0%+15.7%0.351%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.4,810,298$75.71M0.0%+3.0%7.214%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC1,118,417$17.60M0.0%+17.3%1.677%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.1,853,251$29.17M0.1%+6.9%2.779%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC8,109$0.13M0.0%-10.4%0.012%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC1,185,178$18.66M0.0%-10.9%1.777%Search for SEC Filing on Google Icon
11/14/2022Verition Fund Management LLC372,507$5.86M0.1%+11.3%0.559%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC221,424$3.49M0.0%-11.7%0.332%Search for SEC Filing on Google Icon
11/14/2022AXA S.A.18,200$0.29M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/14/2022Integral Health Asset Management LLC340,000$5.35M1.0%+18.9%0.510%Search for SEC Filing on Google Icon
11/10/2022Credit Suisse AG41,392$0.65M0.0%+12.0%0.062%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.26,854$0.42M0.0%N/A0.040%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP48,017$0.76M0.0%N/A0.072%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 7,931$0.13M0.0%-39.9%0.012%Search for SEC Filing on Google Icon
11/9/2022Amalgamated Bank10,453$0.17M0.0%+10.6%0.016%Search for SEC Filing on Google Icon
11/8/2022Allianz Asset Management GmbH21,800$0.34M0.0%-78.2%0.033%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund46,808$0.74M0.0%+20.5%0.070%Search for SEC Filing on Google Icon
11/7/2022Fox Run Management L.L.C.14,928$0.24M0.1%N/A0.022%Search for SEC Filing on Google Icon
11/7/2022Arizona State Retirement System12,665$0.20M0.0%+9.0%0.019%Search for SEC Filing on Google Icon
11/7/2022ProShare Advisors LLC12,730$0.20M0.0%+6.9%0.019%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC16,707$0.26M0.0%-24.0%0.025%Search for SEC Filing on Google Icon
11/1/2022Great West Life Assurance Co. Can1,944$31K0.0%N/A0.003%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC13,598$0.21M0.0%N/A0.020%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC543,776$8.56M2.9%+0.8%0.816%Search for SEC Filing on Google Icon
10/27/2022Assenagon Asset Management S.A.194,923$3.07M0.0%-33.5%0.292%Search for SEC Filing on Google Icon
10/27/2022Strs Ohio19,900$0.31M0.0%+11.2%0.030%Search for SEC Filing on Google Icon
10/26/2022Allspring Global Investments Holdings LLC66,136$1.04M0.0%N/A0.099%Search for SEC Filing on Google Icon
8/30/2022Verition Fund Management LLC334,666$4.67M0.1%+31.0%0.502%Search for SEC Filing on Google Icon
8/22/2022Legal & General Group Plc17,689$0.25M0.0%+6.6%0.027%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.407,889$5.69M0.0%+57.8%0.612%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP621,557$8.68M0.1%N/A0.932%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD38,029$0.53M0.0%+20.5%0.057%Search for SEC Filing on Google Icon
8/16/2022Commodore Capital LP2,410,622$33.65M7.1%+4.1%3.616%Search for SEC Filing on Google Icon
8/15/2022State Street Corp1,230,241$17.17M0.0%+13.6%1.845%Search for SEC Filing on Google Icon
8/15/2022Acuta Capital Partners LLC192,835$2.69M1.5%-11.4%0.289%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC9,050$0.13M0.0%+163.9%0.014%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.1,733,900$24.21M0.1%-23.9%2.601%Search for SEC Filing on Google Icon
8/15/2022Citadel Advisors LLC953,072$13.31M0.0%-2.0%1.429%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC198,794$2.78M0.0%+253.6%0.298%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.86,267$1.20M0.0%+74.8%0.129%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC1,329,678$18.56M0.0%-8.8%1.994%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.28,001$0.39M0.0%+10.6%0.042%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp523,679$7.31M0.0%+11.4%0.785%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG36,942$0.52M0.0%+15.6%0.055%Search for SEC Filing on Google Icon
8/12/2022FMR LLC1,242,308$17.34M0.0%+2.4%1.863%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA13,357$0.19M0.0%+201.8%0.020%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers71,999$1.01M0.0%+30.4%0.108%Search for SEC Filing on Google Icon
8/11/2022Deutsche Bank AG1,174,701$16.40M0.0%-19.9%1.762%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG2,406$34K0.0%+41.4%0.004%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.461,596$6.44M0.0%+933.8%0.692%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.16,157$0.23M0.0%-49.9%0.024%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank101,000$1.41M0.0%-6.9%0.151%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System18,504$0.26M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/3/2022Integral Health Asset Management LLC285,971$3.99M0.8%+20.2%0.430%Search for SEC Filing on Google Icon
8/3/2022Nisa Investment Advisors LLC1,828$26K0.0%N/A0.003%Search for SEC Filing on Google Icon
8/2/2022Requisite Capital Management LLC45,000$0.63M0.2%N/A0.068%Search for SEC Filing on Google Icon
8/1/2022ProShare Advisors LLC11,907$0.17M0.0%-25.1%0.018%Search for SEC Filing on Google Icon
7/28/2022Arizona State Retirement System11,615$0.16M0.0%-6.4%0.017%Search for SEC Filing on Google Icon
7/27/2022Assenagon Asset Management S.A.293,045$4.09M0.0%-42.2%0.440%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.16,245$0.23M0.0%N/A0.024%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC539,545$7.53M2.3%+96.0%0.810%Search for SEC Filing on Google Icon
7/25/2022Strs Ohio17,900$0.25M0.0%N/A0.027%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank8,306$0.14M0.0%N/A0.012%Search for SEC Filing on Google Icon
6/7/2022Teachers Retirement System of The State of Kentucky66,814$1.15M0.0%+7.2%0.100%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE31,314$0.54M0.0%-48.4%0.047%Search for SEC Filing on Google Icon
6/2/2022Verition Fund Management LLC255,478$4.40M0.1%+43.3%0.384%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA4,426$76K0.0%-59.2%0.007%Search for SEC Filing on Google Icon
5/17/2022RA Capital Management L.P.1,817,808$31.34M0.7%N/A2.730%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada3,137$54K0.0%-70.8%0.005%Search for SEC Filing on Google Icon
5/17/2022Rock Springs Capital Management LP3,865,034$66.63M1.7%+0.1%5.805%Search for SEC Filing on Google Icon
5/17/2022Great Point Partners LLC942,445$16.25M3.9%+17.8%1.416%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System60,986$1.05M0.0%-8.2%0.100%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.258,459$4.46M0.0%+16.8%0.422%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP5,730,253$98.79M0.0%+3.4%9.352%Search for SEC Filing on Google Icon
5/16/2022State Street Corp1,083,390$18.68M0.0%+3.4%1.768%Search for SEC Filing on Google Icon
5/16/2022Frazier Life Sciences Management L.P.408,329$7.04M0.6%N/A0.666%Search for SEC Filing on Google Icon
5/16/2022Ghost Tree Capital LLC125,000$2.16M0.5%-61.5%0.204%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG1,702$29K0.0%-96.3%0.003%Search for SEC Filing on Google Icon
5/13/2022Silverarc Capital Management LLC275,333$4.75M2.0%-3.8%0.449%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC1,457,578$25.13M0.0%-13.1%2.379%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp470,166$8.11M0.0%-4.0%0.767%Search for SEC Filing on Google Icon
5/13/2022Verition Fund Management LLC255,478$4.40M0.1%+43.3%0.417%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.133,068$2.30M0.0%+3.2%0.217%Search for SEC Filing on Google Icon
5/13/2022Affinity Asset Advisors LLC100,000$1.72M0.3%-75.0%0.163%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.25,323$0.44M0.0%-6.6%0.041%Search for SEC Filing on Google Icon
5/13/2022Parkman Healthcare Partners LLC668,098$11.52M3.4%-34.9%1.090%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.2,728,820$47.05M0.0%+0.4%4.453%Search for SEC Filing on Google Icon
5/13/2022Allianz Asset Management GmbH81,965$1.41M0.0%+44.2%0.134%Search for SEC Filing on Google Icon
5/12/2022Integral Health Asset Management LLC238,000$4.10M1.1%+19.0%0.388%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.3,987,107$68.74M0.0%-2.2%6.507%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aclaris Therapeutics logo
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.
Read More on Aclaris Therapeutics

Today's Range

Now: $17.53
Low: $17.53
High: $17.83

50 Day Range

MA: $15.98
Low: $13.07
High: $18.37

52 Week Range

Now: $17.53
Low: $9.26
High: $18.96

Volume

65,539 shs

Average Volume

412,158 shs

Market Capitalization

$1.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Who are the company insiders with the largest holdings of Aclaris Therapeutics?

Aclaris Therapeutics' top insider shareholders include:
  1. Neal Walker (CEO)
  2. Andrew N Schiff (Director)
  3. Frank Ruffo (CFO)
  4. David N Gordon (Insider)
  5. Kamil Ali-Jackson (Insider)
  6. Joseph Monahan (Insider)
  7. Andrew N Schiff (Director)
Learn More about top insider investors at Aclaris Therapeutics.

Who are the major institutional investors of Aclaris Therapeutics?

Aclaris Therapeutics' top institutional investors include:
  1. BlackRock Inc. — 7.21%
  2. Vanguard Group Inc. — 4.40%
  3. Point72 Asset Management L.P. — 2.78%
  4. Laurion Capital Management LP — 1.96%
  5. State Street Corp — 1.95%
  6. Renaissance Technologies LLC — 1.78%
Learn More about top institutional investors of Aclaris Therapeutics stock.

Which major investors are selling Aclaris Therapeutics stock?

Within the last quarter, ACRS stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Laurion Capital Management LP
  3. Assenagon Asset Management S.A.
  4. Allianz Asset Management GmbH
  5. Parkman Healthcare Partners LLC
  6. Nuveen Asset Management LLC
  7. Tower Research Capital LLC TRC
  8. Barclays PLC
Within the previous year, company insiders that have sold Aclaris Therapeutics company stock include:
  1. Neal Walker (CEO)
  2. Andrew N Schiff (Director)
  3. Frank Ruffo (CFO)
  4. David N Gordon (Insider)
  5. Kamil Ali-Jackson (Insider)
Learn More investors selling Aclaris Therapeutics stock.

Which major investors are buying Aclaris Therapeutics stock?

During the previous quarter, ACRS stock was acquired by institutional investors including:
  1. Citadel Advisors LLC
  2. BlackRock Inc.
  3. Point72 Asset Management L.P.
  4. Vanguard Group Inc.
  5. Balyasny Asset Management LLC
  6. State Street Corp
  7. Allspring Global Investments Holdings LLC
  8. Integral Health Asset Management LLC